Revolution Medicines, Inc. (NASDAQ:RVMDW) Sees Significant Increase in Short Interest

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totaling 3,115 shares, a growth of 127.5% from the June 15th total of 1,369 shares. Based on an average daily trading volume, of 95,598 shares, the days-to-cover ratio is presently 0.0 days.

Revolution Medicines Price Performance

Shares of Revolution Medicines stock opened at $8.96 on Wednesday. The stock has a 50-day moving average price of $6.88 and a 200 day moving average price of $3.96. Revolution Medicines has a 1 year low of $0.16 and a 1 year high of $10.12.

About Revolution Medicines

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.